<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00890097</url>
  </required_header>
  <id_info>
    <org_study_id>C-08-36</org_study_id>
    <nct_id>NCT00890097</nct_id>
  </id_info>
  <brief_title>Geographic Atrophy Treatment Evaluation</brief_title>
  <acronym>GATE</acronym>
  <official_title>The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the safety and efficacy of AL-8309B Ophthalmic
      Solution versus Vehicle administered as a topical ocular drop for the treatment for
      geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Treatment ineffective
  </why_stopped>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Annualized Lesion Enlargement Rate From Baseline as Assessed With Fundus Autofluorescence Imaging</measure>
    <time_frame>Baseline, up to Month 30</time_frame>
    <description>The size of the retinal lesion was measured using the Heidelberg Retinal Angiography system at Baseline, Month 6, Month 12, Month 15, Month 18, Month 24, and Month 30. Images were collected in both eyes; however, one eye from each subject was chosen as the study eye, and only data for the study eye were used for the efficacy analysis. Results were estimated from a longitudinal random effects regression model. A greater lesion growth rate may indicate a faster progression of the disease.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">772</enrollment>
  <condition>Geographic Atrophy</condition>
  <condition>Age-Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>AL-8309B 1.0%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AL-8309B 1.0% Ophthalmic Solution, 1 drop in each eye twice daily for 30 months, up to a maximum of 36 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AL-8309B 1.75%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AL-8309B 1.75% Ophthalmic Solution, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>AL-8309B Vehicle, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AL-8309B Ophthalmic Solution</intervention_name>
    <arm_group_label>AL-8309B 1.0%</arm_group_label>
    <arm_group_label>AL-8309B 1.75%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AL-8309B Vehicle</intervention_name>
    <description>Inactive ingredients used as placebo comparator</description>
    <arm_group_label>Vehicle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to give written informed consent, make required study visits, and follow
             instructions.

          -  Able to administer eye drops or have a caretaker to administer the eye drops.

          -  Study eye: Atrophy secondary to age-related macular degeneration, best corrected
             visual acuity (BCVA) of 35 letters (20/200 Snellen equivalent) or better, clear ocular
             media, and adequate pupillary dilation.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Pregnant, nursing, or not using adequate contraception.

          -  Ocular disease in the study eye, other than non-exudative AMD.

          -  History of cataract surgery in either eye within the past 3 months of screening.

          -  History or evidence of serious ocular trauma or intraocular surgery in either eye
             within the past 6 months of screening.

          -  Any medical condition that would make participation in the trial or adherence to the
             study schedule difficult or unlikely.

          -  Participation in an investigational drug or device study within 30 days of screening.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sally Scheib, Sr. Clinical Lead</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2009</study_first_posted>
  <results_first_submitted>June 4, 2014</results_first_submitted>
  <results_first_submitted_qc>June 4, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 3, 2014</results_first_posted>
  <disposition_first_submitted>May 9, 2013</disposition_first_submitted>
  <disposition_first_submitted_qc>May 9, 2013</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">May 16, 2013</disposition_first_posted>
  <last_update_submitted>June 4, 2014</last_update_submitted>
  <last_update_submitted_qc>June 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Geographic Atrophy</keyword>
  <keyword>GA</keyword>
  <keyword>Age-Related Macular Degeneration</keyword>
  <keyword>AMD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Geographic Atrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from 48 study centers located in 14 countries.</recruitment_details>
      <pre_assignment_details>This reporting group includes all enrolled subjects (772). A subject was considered enrolled if they met all of the inclusion criteria and none of the exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>AL-8309B 1.0%</title>
          <description>AL-8309B 1.0% Ophthalmic Solution, 1 drop in each eye twice daily for 30 months, up to a maximum of 36 months</description>
        </group>
        <group group_id="P2">
          <title>AL-8309B 1.75%</title>
          <description>AL-8309B 1.75% Ophthalmic Solution, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
        <group group_id="P3">
          <title>Vehicle</title>
          <description>AL-8309B Vehicle, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="252"/>
                <participants group_id="P2" count="259"/>
                <participants group_id="P3" count="261"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="184"/>
                <participants group_id="P2" count="173"/>
                <participants group_id="P3" count="184"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="86"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Decision Unrelated to an Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Noncompliance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor Decision</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not attend final visit</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Randomization Error</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed inclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transportation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Moved</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Deviation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all enrolled subjects (772).</population>
      <group_list>
        <group group_id="B1">
          <title>AL-8309B 1.0%</title>
          <description>AL-8309B 1.0% Ophthalmic Solution, 1 drop in each eye twice daily for 30 months, up to a maximum of 36 months</description>
        </group>
        <group group_id="B2">
          <title>AL-8309B 1.75%</title>
          <description>AL-8309B 1.75% Ophthalmic Solution, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
        <group group_id="B3">
          <title>Vehicle</title>
          <description>AL-8309B Vehicle, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="252"/>
            <count group_id="B2" value="259"/>
            <count group_id="B3" value="261"/>
            <count group_id="B4" value="772"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.9" spread="8.0"/>
                    <measurement group_id="B2" value="78.3" spread="7.7"/>
                    <measurement group_id="B3" value="78.8" spread="7.1"/>
                    <measurement group_id="B4" value="78.3" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="147"/>
                    <measurement group_id="B4" value="439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="114"/>
                    <measurement group_id="B4" value="333"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="112"/>
                    <measurement group_id="B3" value="116"/>
                    <measurement group_id="B4" value="339"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Portugal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Annualized Lesion Enlargement Rate From Baseline as Assessed With Fundus Autofluorescence Imaging</title>
        <description>The size of the retinal lesion was measured using the Heidelberg Retinal Angiography system at Baseline, Month 6, Month 12, Month 15, Month 18, Month 24, and Month 30. Images were collected in both eyes; however, one eye from each subject was chosen as the study eye, and only data for the study eye were used for the efficacy analysis. Results were estimated from a longitudinal random effects regression model. A greater lesion growth rate may indicate a faster progression of the disease.</description>
        <time_frame>Baseline, up to Month 30</time_frame>
        <population>This analysis population included all treated subjects. A subject was considered treated if they had a first or last dosing date in the database.</population>
        <group_list>
          <group group_id="O1">
            <title>AL-8309B 1.0%</title>
            <description>AL-8309B 1.0% Ophthalmic Solution, 1 drop in each eye twice daily for 30 months, up to a maximum of 36 months</description>
          </group>
          <group group_id="O2">
            <title>AL-8309B 1.75%</title>
            <description>AL-8309B 1.75% Ophthalmic Solution, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
          </group>
          <group group_id="O3">
            <title>Vehicle</title>
            <description>AL-8309B Vehicle, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Annualized Lesion Enlargement Rate From Baseline as Assessed With Fundus Autofluorescence Imaging</title>
          <description>The size of the retinal lesion was measured using the Heidelberg Retinal Angiography system at Baseline, Month 6, Month 12, Month 15, Month 18, Month 24, and Month 30. Images were collected in both eyes; however, one eye from each subject was chosen as the study eye, and only data for the study eye were used for the efficacy analysis. Results were estimated from a longitudinal random effects regression model. A greater lesion growth rate may indicate a faster progression of the disease.</description>
          <population>This analysis population included all treated subjects. A subject was considered treated if they had a first or last dosing date in the database.</population>
          <units>square millimeters per year</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="250"/>
                <count group_id="O2" value="258"/>
                <count group_id="O3" value="260"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.725" lower_limit="1.595" upper_limit="1.855"/>
                    <measurement group_id="O2" value="1.758" lower_limit="1.626" upper_limit="1.890"/>
                    <measurement group_id="O3" value="1.707" lower_limit="1.585" upper_limit="1.830"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for the duration of the study (3 years, 2 month). Adverse events were obtained as solicited comments from the study subjects and as observations by the study Investigator as outlined in the study protocol.</time_frame>
      <desc>This analysis population includes all treated subjects (768).</desc>
      <group_list>
        <group group_id="E1">
          <title>AL-8309B 1.0%</title>
          <description>AL-8309B 1.0% Ophthalmic Solution, 1 drop in each eye twice daily for 30 months, up to a maximum of 36 months</description>
        </group>
        <group group_id="E2">
          <title>AL-8309B 1.75%</title>
          <description>AL-8309B 1.75% Ophthalmic Solution, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
        <group group_id="E3">
          <title>Vehicle</title>
          <description>AL-8309B Vehicle, 1 drop in each eye twice daily, for 30 months up to a maximum of 36 months</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="85" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Bundle branch block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sinus arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Choledochal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intussusception</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Biliary tract disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dacryocystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Echinococciasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pancreatic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intraocular lens dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arthroscopy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Endoscopy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Investigation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Renal function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Kyphosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Temporomandibular joint syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac valve fibroelastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant non-resectable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Metastases to abdominal cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma non-resectable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Ureteric cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cerebral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Syringomyelia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pelvi-ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Vaginal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Aortic valve repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Appendicectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Bunion operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Haemorrhoid operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hip surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Intrathecal pump insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Joint arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Keratoplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Malignant tumour excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Radiotherapy to eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Salivary gland operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Scoliosis surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Spinal operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Vasodilation procedure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="207" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="212" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="207" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Choroidal neovascularisation</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="107" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="109" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="260"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="258"/>
                <counts group_id="E3" subjects_affected="36" subjects_at_risk="260"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dana Sager, Clinical Manager Group Leader</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

